Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 21, 2020

SELL
$16.46 - $27.42 $164,698 - $274,364
-10,006 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$14.46 - $21.8 $17,684 - $26,661
-1,223 Reduced 10.89%
10,006 $172,000
Q4 2019

Feb 13, 2020

BUY
$15.15 - $18.89 $170,119 - $212,115
11,229 New
11,229 $198,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Parcion Private Wealth LLC Portfolio

Follow Parcion Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parcion Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parcion Private Wealth LLC with notifications on news.